Klaus Sindahl

Investor Relations Contact at HANSA BIOPHARMA AB

Process Industries

Health Technology

Profile

Klaus Sindahl is currently the Head of Investor Relations at Hansa Biopharma AB since 2019.
Prior to this, he worked at Novozymes A for 12 years from 2006 to 2018 as an Investor Relations Officer.

Klaus Sindahl active positions

Companies	Position	Start
HANSA BIOPHARMA AB	Investor Relations Contact	2019-04-28

All active positions of Klaus Sindahl

Former positions of Klaus Sindahl

Companies	Position	End
Novozymes A/S Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.	Public Communications Contact	2017-12-31

See the detail of Klaus Sindahl's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Klaus Sindahl's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
HANSA BIOPHARMA AB	Health Technology

Private companies	1
Novozymes A/S Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.	Process Industries